J&J’s Covid-19 vaccine may trigger neurological condition in rare cases, FDA says
Johnson & Johnson’s Covid-19 vaccine may trigger a rare neurological condition in a small number of people who receive the vaccine, the Food and Drug Administration said Monday.
Reports to a database operated jointly by the agency and the Centers for Disease Prevention and Control suggest there may be a link between the inoculations and Guillain Barré syndrome, a form of progressive paralysis that is generally reversible, the FDA said in a statement.
